Cyclo Therapeutics - Stock Price History | CYTH
Historical daily share price chart and data for Cyclo Therapeutics since 2021 adjusted for splits. The latest closing stock price for Cyclo Therapeutics as of September 27, 2021 is 7.33.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high Cyclo Therapeutics stock closing price was 13.33 on February 09, 2021.
- The Cyclo Therapeutics 52-week high stock price is 17.75, which is 142.2% above the current share price.
- The Cyclo Therapeutics 52-week low stock price is 3.55, which is 51.6% below the current share price.
- The average Cyclo Therapeutics stock price for the last 52 weeks is 7.92.
|Cyclo Therapeutics Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
Cyclo Therapeutics Inc. is a clinical-stage biotechnology company. It develops cyclodextrin-based products for the treatment of disease. The company's Trappsol(R) Cyclo(TM), an orphan drug designated product primarily in the United States and Europe, is in ongoing formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease. Cyclo Therapeutics Inc., formerly known as CTD Holdings Inc., is based in ALACHUA, Fla.